by Clare Gerrard | Sep 27, 2023 | News, Patient Stories
I first met Barrie, not long after I joined Neuroendocrine Cancer UK, about 7 years ago, at a Natter group: one he co-founded and facilitated in Letchworth Garden City. He’d been diagnosed with Neuroendocrine Cancer in 2008, and first became aware of and involved with... by Leanne Talbot | Jun 24, 2020
There is a voiced genuine concern regarding the huge impact the Covid-19 Pandemic has had, and will have, on healthcare for patients with cancer. To understand the impact this has had on the Neuroendocrine Cancer Community, a group often thought of as more... by Leanne Talbot | Jun 22, 2020
The UK Government has set out a roadmap for the clinically extremely vulnerable on the future of the shielding programme. For now, the guidance remains the same – stay at home and only go outside to exercise or to spend time outdoors with a member of your household,... by Leanne Talbot | Jun 19, 2020
Mylan is experiencing a temporary supply constraint of Creon 25K. AAH, Alliance & Phoenix wholesalers last received stock of the 25k, 16th and 17th June 2020, varying by depot. Pharmacies should contact their preferred wholesaler for availability, although, we... by Leanne Talbot | Jun 11, 2020
ENETS will host a series of conversations with NET experts in two separate webinars on 11 June 2020. In these webinars, we will interview a panel of NET experts from high-volume Covid areas. The webinars will enable NET physicians to share their experiences and learn... by Leanne Talbot | Jun 4, 2020
Neuroendocrine neoplasia is described in almost every tissue, either in the pure endocrine organs, the nerve structures or in the so-called diffuse neuroendocrine system. The current nomenclature contains time-honored, widely accepted definitions; however, it is... 
